Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosa Alba Eufemiese"'
Autor:
Jessica Burroughs Garcìa, Rosa Alba Eufemiese, Paola Storti, Gabriella Sammarelli, Luisa Craviotto, Giannalisa Todaro, Denise Toscani, Valentina Marchica, Nicola Giuliani
Publikováno v:
Cells, Vol 10, Iss 6, p 1360 (2021)
Multiple myeloma (MM) is characterized by an accumulation of malignant plasma cells (PCs) in the bone marrow (BM). The amplification of 1q21 is one of the most common cytogenetic abnormalities occurring in around 40% of de novo patients and 70% of re
Externí odkaz:
https://doaj.org/article/516b2d27c6dd45828a1edaa5549a9cea
Autor:
Gabriella Sammarelli, Denise Toscani, Valentina Marchica, Nicola Giuliani, Rosa Alba Eufemiese, Luisa Craviotto, Jessica Burroughs Garcìa, Giannalisa Todaro, Paola Storti
Publikováno v:
Cells
Cells, Vol 10, Iss 1360, p 1360 (2021)
Cells, Vol 10, Iss 1360, p 1360 (2021)
Multiple myeloma (MM) is characterized by an accumulation of malignant plasma cells (PCs) in the bone marrow (BM). The amplification of 1q21 is one of the most common cytogenetic abnormalities occurring in around 40% of de novo patients and 70% of re
Autor:
Giancarlo Pruneri, Giuseppe Taurino, Luca Agnelli, Massimiliano G. Bianchi, Benedetta Dalla Palma, Valentina Franceschi, Giovanna D'Amico, Gaetano Donofrio, Jessica Burroughs-Garcia, Federica Costa, Roberta Andreoli, Ovidio Bussolati, Eugenia Martella, Nicoletta Campanini, Cristina Mancini, Rosa Alba Eufemiese, Erica Dander, Martina Chiu, Michael S. Kilberg, Denise Toscani, Valentina Marchica, Paola Storti, Nicola Giuliani, Jixiu Shan
Publikováno v:
Cancers, Vol 12, Iss 3267, p 3267 (2020)
Cancers
Volume 12
Issue 11
Cancers
Volume 12
Issue 11
Simple Summary Osteolytic bone lesions represent an important clinical feature of multiple myeloma (MM). MM cells metabolize very high amounts of glutamine (Gln) and significantly lower Gln in the bone marrow. In this contribution we demonstrate that
Autor:
Federica Costa, Nicola Giuliani, Rosa Alba Eufemiese, Benedetta Dalla Palma, Valentina Marchica, Denise Toscani, Paola Storti, Jessica Burroughs-Garcia
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2864, p 2864 (2020)
Journal of Clinical Medicine, Vol 9, Iss 2864, p 2864 (2020)
The monoclonal antibodies (mAbs) have significantly changed the treatment of multiple myeloma (MM) patients. However, despite their introduction, MM remains an incurable disease. The mAbs currently used for MM treatment were developed with different